Evertrue Capital Joins the 12,000-Fund AI/Fintech Pile

Evertrue Capital, the debut fund from Yvonne Bajela, has announced $17 million in fresh capital earmarked for early-stage artificial intelligence and fintech startups across Europe. This represents the launch moment for what will almost certainly become another commodity player in a market so saturated with identical mandates that venture partners could be replaced by a random number generator trained on TechCrunch headlines from the last eighteen months. The fund size itself—$17 million—sits in that awkward middle zone where it's too small to write meaningful checks into Series A rounds but large enough to create the illusion of legitimacy.

Evertrue Capital's thesis, such as it exists, targets "early-stage AI and fintech." This is approximately as specific as saying you invest in "companies with revenue models" or "startups founded by humans." The European fintech space alone hosts somewhere north of 5,000 active startups competing for capital, each claiming a marginally different angle on payments, lending, or wealth management—none of which Evertrue has apparently decided to prioritize over the others. Similarly, every institutional LP who has answered a phone in the past thirty-six months has heard the same AI pitch delivered with the same breathless conviction, usually by someone who discovered transformers three months ago and now considers themselves a vertical expert.

There is no public information suggesting Bajela or her team has successfully deployed capital into early-stage technology companies before, which is precisely the problem with the current vintage of VC formations: the barrier to entry has become purely capital-raising competence rather than investment acumen. The fund market has reached a state where announcing a debut vehicle generates press coverage automatically, regardless of the founder's track record, because publishing bad news about capital availability contradicts the narrative that the ecosystem remains robust and innovative. Evertrue joins approximately 11,987 other debut or quasi-debut funds making structurally identical bets on structurally identical problems.

In the inevitable press materials—and there will be press materials—expect language about "supporting the next generation of fintech innovators" and "democratizing access to AI-driven solutions." These phrases function as professional placeholders, the verbal equivalent of a blank check written to yourself. "Early-stage" almost certainly means post-MVP but pre-product-market-fit, which is the graveyard tier of startup investing where capital gets distributed to ideas that are simultaneously too developed to be real venture bets and too underdeveloped to demonstrate actual unit economics or defensibility.

The historical record of $17 million debut funds targeting broad early-stage mandates in crowded verticals is genuinely dismal. Most will deploy capital unevenly, milk management fees for three to four years while waiting for one portfolio company to exit and paper-hand a 0.8x return to LPs, then quietly shut down without a Series II announcement. Some will make one genuinely good investment that succeeds despite rather than because of the fund's involvement, and those founders will spend five years being grateful to people who wrote tiny checks at moments of maximum validation.

What Evertrue's $17 million truly represents is the final stage of VC market saturation: not the absence of capital, but the presence of so much capital chasing so few genuinely novel investment theses that new funds must resort to exact replication of their competitors' strategies, with identical sector focuses, identical stage preferences, and identical geographic footprints. The only differentiator left is luck, which is not a differentiator at all.

Congratulations to Evertrue on joining the party. The exit line is around the corner.